Masimo | MASI - Gross Profit On Sales



Masimo reported $233.3M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Abbott USD 5.87B 50M Jun/2025
Align Technology USD 708.12M 28.01M Jun/2025
AtriCure USD 101.48M 8.85M Jun/2025
Avanos Medical USD 92.1M 2.3M Jun/2025
Baxter International USD 1.14B 283M Jun/2025
Becton, Dickinson and Co. USD 2.63B 377M Jun/2025
Boston Scientific USD 3.42B 228M Jun/2025
Dexcom USD 688.8M 99.8M Jun/2025
Edwards Lifesciences USD 1.19B 76.7M Jun/2025
General Electric Aerospace USD 4.02B 286M Jun/2025
Globus Medical USD 1.21B 809.01M Jun/2025
Haemonetics USD 192.24M 806K Jun/2025
Insulet USD 452.2M 43.2M Jun/2025
Integra LifeSciences USD 209.33M 5.81M Jun/2025
Intuitive Surgical USD 1.62B 160.2M Jun/2025
Masimo USD 233.3M 700K Jun/2025
Medtronic USD 5.12B 695M Jul/2025
Owens Minor USD 526.01M 53.75M Mar/2025
ResMed USD 827.92M 61.52M Jun/2025
Steris USD 628M 13.21M Jun/2025
Stryker USD 3.84B 30M Jun/2025
Tandem Diabetes Care USD 125.85M 7.45M Jun/2025
Teleflex USD 431.08M 41.65M Jun/2025
Thermo Fisher Scientific USD 4.05B 260M Jun/2025
Zimmer Biomet Holdings USD 1.32B 34.8M Jun/2025